WallStreetZenWallStreetZen

NASDAQ: SLN
Silence Therapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SLN

Based on 5 analysts offering 12 month price targets for Silence Therapeutics PLC

Min Forecast
$3.00-43.71%
Avg Forecast
$32.60+511.63%
Max Forecast
$75.00+1,307.13%

Should I buy or sell SLN stock?

Based on 5 analysts offering ratings for Silence Therapeutics PLC.

Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 20%
Although SLN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SLN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SLN stock forecasts and price targets.

SLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-13
lockedlocked$00.00+00.00%2025-06-13
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-05-09
lockedlocked$00.00+00.00%2025-03-04

1 of 1

Forecast return on equity

Is SLN forecast to generate an efficient return?

Company
-914.92%
Industry
140.91%
Market
90.47%
SLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLN forecast to generate an efficient return on assets?

Company
556.68%
Industry
32.45%
SLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLN earnings per share forecast

What is SLN's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.13
Avg 2 year Forecast
-$1.07
Avg 3 year Forecast
$2.61

SLN revenue forecast

What is SLN's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$30.4M+8.97%
Avg 2 year Forecast
$20.5M-26.57%
Avg 3 year Forecast
$214.7M+669.81%
SLN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SLN revenue growth forecast

How is SLN forecast to perform vs Biotechnology companies and vs the US market?

Company
84.05%
Industry
56.38%
Market
9.68%
SLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLN$5.33$32.60+511.63%Buy
IMMP$1.74N/AN/A
CRDF$3.81$18.00+372.44%Buy
NBTX$5.35$8.00+49.67%Strong Buy
DBVT$9.10$14.81+62.78%Hold
View Top Biotech Stocks

Silence Therapeutics Stock Forecast FAQ

Is Silence Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: SLN) stock is to Buy SLN stock.

Out of 5 analysts, 2 (40%) are recommending SLN as a Strong Buy, 2 (40%) are recommending SLN as a Buy, 0 (0%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 1 (20%) are recommending SLN as a Strong Sell.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.

What is SLN's earnings growth forecast for 2025-2027?

(NASDAQ: SLN) Silence Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Silence Therapeutics's earnings in 2025 is -$71,494,000.On average, 4 Wall Street analysts forecast SLN's earnings for 2025 to be -$160,110,661, with the lowest SLN earnings forecast at -$279,130,975, and the highest SLN earnings forecast at -$32,588,896. On average, 5 Wall Street analysts forecast SLN's earnings for 2026 to be -$151,042,446, with the lowest SLN earnings forecast at -$273,463,341, and the highest SLN earnings forecast at -$53,842,523.

In 2027, SLN is forecast to generate $370,167,346 in earnings, with the lowest earnings forecast at -$279,130,975 and the highest earnings forecast at $1,935,497,011.

What is SLN's revenue growth forecast for 2025-2027?

(NASDAQ: SLN) Silence Therapeutics's forecast annual revenue growth rate of 84.05% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Silence Therapeutics's revenue in 2025 is $27,892,500.On average, 5 Wall Street analysts forecast SLN's revenue for 2025 to be $4,306,551,695, with the lowest SLN revenue forecast at $77,929,968, and the highest SLN revenue forecast at $15,227,515,650. On average, 5 Wall Street analysts forecast SLN's revenue for 2026 to be $2,902,111,990, with the lowest SLN revenue forecast at $75,096,151, and the highest SLN revenue forecast at $6,764,321,179.

In 2027, SLN is forecast to generate $30,423,859,312 in revenue, with the lowest revenue forecast at $2,683,624,699 and the highest revenue forecast at $102,953,988,519.

What is SLN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SLN) forecast ROA is 556.68%, which is higher than the forecast US Biotechnology industry average of 32.45%.

What is SLN's Price Target?

According to 5 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $32.60, with the highest SLN stock price forecast at $75.00 and the lowest SLN stock price forecast at $3.00.

On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $32.60 by Jun 13, 2026. The average Silence Therapeutics stock price prediction forecasts a potential upside of 511.63% from the current SLN share price of $5.33.

What is SLN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SLN) Silence Therapeutics's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that SLN's EPS will be -$1.13 for 2025, with the lowest EPS forecast at -$1.97, and the highest EPS forecast at -$0.23. On average, analysts forecast that SLN's EPS will be -$1.07 for 2026, with the lowest EPS forecast at -$1.93, and the highest EPS forecast at -$0.38. In 2027, SLN's EPS is forecast to hit $2.61 (min: -$1.97, max: $13.66).

What is SLN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SLN) forecast ROE is -914.92%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.